The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology

Vale, 1981, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin., Science, 213, 1394, 10.1126/science.6267699

Vaughan, 1995, Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor., Nature, 378, 287, 10.1038/378287a0

Reyes, 2001, Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors., Proc Natl Acad Sci USA, 98, 2843, 10.1073/pnas.051626398

Lewis, 2001, Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor., Proc Natl Acad Sci USA, 98, 7570, 10.1073/pnas.121165198

Hsu, 2001, Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor., Nat Med, 7, 605, 10.1038/87936

Denver, 1999, Evolution of the corticotropin-releasing hormone signaling system and its role in stress-induced phenotypic plasticity., Ann NY Acad Sci, 897, 46, 10.1111/j.1749-6632.1999.tb07877.x

Rivier, 1982, In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, β-endorphin, and corticosterone., Endocrinology, 110, 272, 10.1210/endo-110-1-272

Pavlov, 1986, Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men., J Clin Endocrinol Metab, 62, 767, 10.1210/jcem-62-4-767

Stenzel-Poore, 1992, Development of Cushing’s syndrome in corticotropin-releasing factor transgenic mice., Endocrinology, 130, 3378, 10.1210/endo.130.6.1597149

Muglia, 1995, Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need., Nature, 373, 427, 10.1038/373427a0

Diamant, 1991, Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats., Endocrinology, 129, 446, 10.1210/endo-129-1-446

Silverman, 1989, Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus., Neuroendocrinology, 49, 291, 10.1159/000125131

Oshima, 2003, Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775., Neuropsychopharmacology, 28, 2148, 10.1038/sj.npp.1300267

Jedema, 2004, Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro., J Neurosci, 24, 9703, 10.1523/JNEUROSCI.2830-04.2004

Glowa, 1991, Selective anorexigenic effects of corticotropin releasing hormone in the rhesus monkey., Prog Neuropsychopharmacol Biol Psychiatry, 15, 379, 10.1016/0278-5846(91)90069-D

Uehara, 1998, Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin., Diabetes, 47, 890, 10.2337/diabetes.47.6.890

Richard, 2000, The corticotropin-releasing hormone system in the regulation of energy balance in obesity, Int J Obes Relat Metab Disord, 24, S36, 10.1038/sj.ijo.0801275

Baigent, 2001, Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response., Peptides, 22, 809, 10.1016/S0196-9781(01)00395-3

Makrigiannakis, 2001, Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance., Nat Immunol, 11, 1018, 10.1038/ni719

McLean, 1995, A placental clock controlling the length of human pregnancy., Nat Med, 1, 460, 10.1038/nm0595-460

Grammatopoulos, 1999, Role of corticotropin-releasing hormone in onset of labour., Lancet, 354, 1546, 10.1016/S0140-6736(99)03418-2

Jones, 1990, The Cushing syndromes., Pediatr Clin North Am, 37, 1313, 10.1016/S0031-3955(16)37013-4

Sarnyai, 2001, The role of corticotropin-releasing factor in drug addiction., Pharmacol Rev, 53, 209

Heinrichs, 1999, Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders., Baillieres Best Pract Res Clin Endocrinol Metab, 13, 541, 10.1053/beem.1999.0042

Chrousos, 2000, The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes, Int J Obes Relat Metab Disord, 24, S50, 10.1038/sj.ijo.0801278

Gold, 2002, Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states., Mol Psychiatry, 7, 254, 10.1038/sj.mp.4001032

Wahle, 2002, Immunopathogenesis of rheumatic diseases in the context of neuroendocrine interactions., Ann NY Acad Sci, 966, 355, 10.1111/j.1749-6632.2002.tb04235.x

Skelton, 2000, The neurobiology of urocortin., Regul Pept, 93, 85, 10.1016/S0167-0115(00)00180-4

Martinez, 2004, Urocortins and the regulation of gastrointestinal motor function and visceral pain., Peptides, 25, 1733, 10.1016/j.peptides.2004.05.025

Li, 2002, Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression., J Neurosci, 22, 991, 10.1523/JNEUROSCI.22-03-00991.2002

Fukuda, 2005, Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders., J Clin Endocrinol Metab, 90, 4671, 10.1210/jc.2005-0090

Takahashi, 2004, Expression of urocortin III/stresscopin in human heart and kidney., J Clin Endocrinol Metab, 89, 1897, 10.1210/jc.2003-031663

Wang, 2002, Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response., Mol Cell Biol, 22, 6605, 10.1128/MCB.22.18.6605-6610.2002

Spina, 1996, Appetite-suppressing effects of urocortin, a CRF-related neuropeptide., Science, 273, 1561, 10.1126/science.273.5281.1561

Bale, 2004, The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure., Proc Natl Acad Sci USA, 101, 3697, 10.1073/pnas.0307324101

Bale, 2003, A new role for corticotropin-releasing factor receptor-2: suppression of vascularization., Trends Cardiovasc Med, 13, 68, 10.1016/S1050-1738(02)00214-1

Behan, 1995, Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides., Front Neuroendocrinol, 16, 362, 10.1006/frne.1995.1013

Potter, 1992, The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF., Proc Natl Acad Sci USA, 89, 4192, 10.1073/pnas.89.9.4192

Lovejoy, 1998, Ectopic expression of the CRF-binding protein: minor impact on HPA axis regulation but induction of sexually dimorphic weight gain., J Neuroendocrinol, 10, 483, 10.1046/j.1365-2826.1998.00206.x

Petraglia, 1993, Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues., J Clin Endocrinol Metab, 77, 919

Suda, 1988, Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy., J Clin Endocrinol Metab, 67, 1278, 10.1210/jcem-67-6-1278

Woods, 1994, Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex., J Clin Endocrinol Metab, 78, 73

Burrows, 1998, Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice., J Clin Invest, 101, 1439, 10.1172/JCI1963

Karolyi, 1999, Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice., Proc Natl Acad Sci USA, 96, 11595, 10.1073/pnas.96.20.11595

Chen, 1993, Expression cloning of a human corticotropin-releasing-factor receptor., Proc Natl Acad Sci USA, 90, 8967, 10.1073/pnas.90.19.8967

Lovenberg, 1995, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain., Proc Natl Acad Sci USA, 92, 836, 10.1073/pnas.92.3.836

Vamvakopoulos, 1994, Human corticotropin-releasing hormone receptor gene (CRHR) is located on the long arm of chromosome 17 (17q12-qter)., Chromosome Res, 2, 471, 10.1007/BF01552870

Meyer, 1997, Localization of the human CRF2 receptor to 7p21–p15 by radiation hybrid mapping and FISH analysis., Genomics, 40, 189, 10.1006/geno.1996.4521

Burrows, 1995, Localization of the corticotropin-releasing hormone receptor gene on mouse chromosome 11., Mamm Genome, 6, 55, 10.1007/BF00350896

Lesh, 1997, Mapping of the mouse corticotropin-releasing hormone receptor 2 gene (Crhr2) to chromosome 6., Mamm Genome, 8, 944, 10.1007/s003359900644

Oliveira, 2004, Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype., Neurogenetics, 5, 147, 10.1007/s10048-004-0180-5

Chang, 2004, Ancient evolution of stress-regulating peptides in vertebrates., Peptides, 25, 1681, 10.1016/j.peptides.2004.05.022

Audsley, 1995, Cross reactivity studies of CRF-related peptides on insect Malpighian tubules., Comp Biochem Physiol A Physiol, 110, 87, 10.1016/0300-9629(94)00132-D

Johnson, 2004, Drosophila CG8422 encodes a functional diuretic hormone receptor., J Exp Biol, 207, 743, 10.1242/jeb.00818

Van Pett, 2000, Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse., J Comp Neurol, 428, 191, 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U

Heinrich, 1998, Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse Leydig cells through CRF receptor-1., Endocrinology, 139, 651, 10.1210/endo.139.2.5754

Asakura, 1997, Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary., J Clin Endocrinol Metab, 82, 2720

Di Blasio, 1997, Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells., J Clin Endocrinol Metab, 82, 1594, 10.1210/jcem.82.5.3923

Grammatopoulos, 1998, Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria., J Clin Endocrinol Metab, 83, 2539

Karteris, 1998, The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1α (CRH-1α) and the CRH-C variant receptor., J Clin Endocrinol Metab, 83, 1376

Karteris, 2001, Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals., J Clin Endocrinol Metab, 86, 4512, 10.1210/jcem.86.9.7849

Seres, 2004, Corticotropin-releasing hormone system in human adipose tissue., J Clin Endocrinol Metab, 89, 965, 10.1210/jc.2003-031299

Pisarchik, 2001, Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression., FASEB J, 15, 2754, 10.1096/fj.01-0487fje

Radulovic, 1999, Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells., J Immunol, 162, 3013, 10.4049/jimmunol.162.5.3013

Kimura, 2002, Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart., J Clin Endocrinol Metab, 87, 340, 10.1210/jcem.87.1.8160

Agelaki, 2002, Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice., Infect Immun, 70, 6068, 10.1128/IAI.70.11.6068-6074.2002

Perrin, 1995, Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart., Proc Natl Acad Sci USA, 92, 2969, 10.1073/pnas.92.7.2969

Kageyama, 2003, Regulation of corticotropin-releasing factor receptor type 2β mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells., Cell Signal, 15, 17, 10.1016/S0898-6568(02)00048-7

Smith, 1998, Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development., Neuron, 20, 1093, 10.1016/S0896-6273(00)80491-2

Timpl, 1998, Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1., Nat Genet, 19, 162, 10.1038/520

Bale, 2000, Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress., Nat Genet, 24, 410, 10.1038/74263

Kishimoto, 2000, Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2., Nat Genet, 24, 415, 10.1038/74271

Coste, 2000, Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2., Nat Genet, 24, 403, 10.1038/74255

Bale, 2004, CRF and CRF receptors: role in stress responsivity and other behaviors., Annu Rev Pharmacol Toxicol, 244, 525, 10.1146/annurev.pharmtox.44.101802.121410

Blaukat, 2001, Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function., J Biol Chem, 276, 40431, 10.1074/jbc.M107024200

Brar, 2004, Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart., Endocrinology, 145, 24, 10.1210/en.2003-0689

Wiley, 2004, CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators., Br J Pharmacol, 143, 508, 10.1038/sj.bjp.0705985

Friedberg, 2003, Modulation of 11 β-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers., J Clin Endocrinol Metab, 88, 385, 10.1210/jc.2002-020510

Porcher, 2005, Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine, Am J Physiol Gastrointest Liver Physiol, 288, G1091, 10.1152/ajpgi.00302.2004

Martinez, 2004, Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice., J Physiol, 556, 221, 10.1113/jphysiol.2003.059659

Makrigiannakis, 2004, Participation of maternal and fetal CRH in early phases of human implantation: the role of antalarmin., Curr Drug Targets Immune Endocr Metabol Disord, 4, 75, 10.2174/1568008043339992

Hillhouse, 2002, Role of stress peptides during human pregnancy and labour., Reproduction, 124, 323, 10.1530/rep.0.1240323

Bale, 2002, Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization., Proc Natl Acad Sci USA, 99, 7734, 10.1073/pnas.102187099

Zouboulis, 2002, Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes., Proc Natl Acad Sci USA, 99, 7148, 10.1073/pnas.102180999

Cao, 2005, Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor., J Immunol, 174, 7665, 10.4049/jimmunol.174.12.7665

Karteris, 2004, Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium., J Mol Endocrinol, 32, 21, 10.1677/jme.0.0320021

Tsai-Morris, 1996, The genomic structure of the rat corticotropin releasing factor receptor. A member of the class II G protein-coupled receptors., J Biol Chem, 271, 14519, 10.1074/jbc.271.24.14519

Gorn, 1995, Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction., J Clin Invest, 95, 2680, 10.1172/JCI117970

Ross, 1994, A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology., Biochem Biophys Res Commun, 205, 1836, 10.1006/bbrc.1994.2884

Grammatopoulos, 1999, Novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes., Mol Endocrinol, 13, 2189, 10.1210/mend.13.12.0391

Grammatopoulos, 1999, Activation of protein kinase C by oxytocin inhibits the biological activity of the human myometrial CRH receptor at term., Endocrinology, 140, 585, 10.1210/endo.140.2.6530

Pisarchik, 2002, Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin., J Invest Dermatol, 118, 1065, 10.1046/j.1523-1747.2002.01770.x

Wille, 1999, Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding., J Neurochem, 72, 388, 10.1046/j.1471-4159.1999.0720388.x

Seck, 2005, The Δe13 isoform of the calcitonin receptor forms a six transmembrane domain receptor with dominant negative effects on receptor surface expression and signalling., Mol Endocrinol, 19, 2132, 10.1210/me.2004-0472

Ding, 1995, Identification of an alternative spliced form of PTH/PTHrP receptor mRNA in immortalized renal tubular cells, J Bone Miner Res, 10, S484

Grinninger, 2004, A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function., J Biol Chem, 279, 40259, 10.1074/jbc.C400332200

Karteris, 2003, Program of the 85th Annual Meeting of The Endocrine Society, 313

Seck, 2003, The alternatively spliced Δe13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression., J Biol Chem, 278, 23085, 10.1074/jbc.M211280200

Pisarchik, 2004, Molecular and functional characterization of novel CRFR1 isoforms from the skin., Eur J Biochem, 271, 2821, 10.1111/j.1432-1033.2004.04216.x

Parham, 2004, Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin., Endocrinology, 145, 3971, 10.1210/en.2004-0194

Makino, 2002, Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress., Pharmacol Biochem Behav, 73, 147, 10.1016/S0091-3057(02)00791-8

Brunson, 2002, Corticotropin-releasing hormone (CRH) down-regulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain., Exp Neurol, 176, 75, 10.1006/exnr.2002.7937

Mansi, 1996, Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF., Endocrinology, 137, 4619, 10.1210/endo.137.11.8895325

Kasagi, 2002, Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells., J Neuroendocrinol, 14, 587, 10.1046/j.1365-2826.2002.00816.x

Luo, 1995, Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids., Endocrinology, 136, 3877, 10.1210/endo.136.9.7649095

Zhou, 1996, Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA., Peptides, 17, 435, 10.1016/0196-9781(96)00014-9

Adler, 1988, Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line., J Biol Chem, 263, 5846, 10.1016/S0021-9258(18)60643-X

Frim, 1990, Differential regulation of corticotropin-releasing hormone mRNA in rat brain, Am J Physiol, 258, E686

Rosen, 1992, Effects of glucocorticoid on corticotropin-releasing hormone gene regulation by second messenger pathways in NPLC and AtT-20 cells., Endocrinology, 130, 2237

Kishimoto, 1995, A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle., Proc Natl Acad Sci USA, 92, 1108, 10.1073/pnas.92.4.1108

Valdenaire, 1997, A new functional isoform of the human CRF2 receptor for corticotropin-releasing hormone., Biochim Biophys Acta, 1352, 129, 10.1016/S0167-4781(97)00047-X

Kostich, 1998, Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2γ receptor., Mol Endocrinol, 12, 1077

Catalano, 2003, Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants., Mol Endocrinol, 17, 395, 10.1210/me.2002-0302

Lovenberg, 1995, CRF2a and CRF2b receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues., Endocrinology, 136, 4139, 10.1210/endo.136.9.7544278

Miyata, 2001, Localization and characterization of a short isoform of the corticotropin-releasing factor receptor type 2α (CRF(2) α-tr) in the rat brain., Biochem Biophys Res Commun, 280, 553, 10.1006/bbrc.2000.4112

Chen, 2005, A soluble mouse brain splice variant of type 2α corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity., Proc Natl Acad Sci USA, 102, 2620, 10.1073/pnas.0409583102

Muller, 2001, Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation., Endocrinology, 142, 4150, 10.1210/endo.142.9.8491

Kageyama, 2000, Regulation of corticotropin-releasing factor receptor type 2β messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines., Endocrinology, 141, 2285, 10.1210/endo.141.7.7572

Makino, 1998, Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation, Am J Physiol, 275, R1138

Chen, 2005, Mouse corticotropin-releasing factor receptor type 2α gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids., Mol Endocrinol, 19, 441, 10.1210/me.2004-0300

Nishiyama, 1999, Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat., J Neuroendocrinol, 11, 307, 10.1046/j.1365-2826.1999.00331.x

Makino, 1999, Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress., Neuroendocrinology, 70, 160, 10.1159/000054472

Eghbal-Ahmadi, 1997, Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation., Endocrinology, 138, 5048, 10.1210/endo.138.11.5647

Dieterich, 1998, Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas., J Clin Endocrinol Metab, 83, 3327

Hiroi, 2001, Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls., Mol Psychiatry, 6, 540, 10.1038/sj.mp.4000908

Merali, 2004, Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region., J Neurosci, 24, 1478, 10.1523/JNEUROSCI.4734-03.2004

Karteris, 2003, Reduced expression of corticotropin-releasing hormone receptor type-1 α in human preeclamptic and growth-restricted placentas., J Clin Endocrinol Metab, 88, 363, 10.1210/jc.2002-020375

Karteris, 2005, Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides., J Clin Endocrinol Metab, 90, 3680, 10.1210/jc.2004-2210

Behan, 1996, Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders., Mol Psychiatry, 1, 265

Eckart, 2001, A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists., Proc Natl Acad Sci USA, 98, 11142, 10.1073/pnas.211424998

Tezval, 2004, Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model., Proc Natl Acad Sci USA, 101, 9468, 10.1073/pnas.0403159101

Beyermann, 2000, A role for a helical connector between two receptor binding sites of a long-chain peptide hormone., J Biol Chem, 275, 5702, 10.1074/jbc.275.8.5702

Nielsen, 2000, Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras., Proc Natl Acad Sci USA, 97, 10277, 10.1073/pnas.97.18.10277

Jahn, 2001, Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs., Peptides, 22, 47, 10.1016/S0196-9781(00)00356-9

Sutton, 1995, Ligand requirements of the human corticotropin-releasing factor-binding protein., Endocrinology, 136, 1097, 10.1210/endo.136.3.7867564

Mazur, 2004, Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides., J Med Chem, 47, 3450, 10.1021/jm049883l

Jahn, 2004, Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity., Neuropharmacology, 47, 233, 10.1016/j.neuropharm.2004.03.018

Gulyas, 1995, Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor., Proc Natl Acad Sci USA, 92, 10575, 10.1073/pnas.92.23.10575

Perrin, 2001, Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor., J Biol Chem, 276, 31528, 10.1074/jbc.M101838200

Perrin, 2003, A soluble form of the first extracellular domain of mouse type 2β corticotropin-releasing factor receptor reveals differential ligand specificity., J Biol Chem, 278, 15595, 10.1074/jbc.M210476200

Grauschopf, 2000, The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern., Biochemistry, 39, 8878, 10.1021/bi0001426

Grace, 2004, NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor., Proc Natl Acad Sci USA, 101, 12836, 10.1073/pnas.0404702101

Hoare, 2005, Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity., Peptides, 26, 457, 10.1016/j.peptides.2004.10.019

Ruhmann, 1998, Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2β-selective antisauvagine-30., Proc Natl Acad Sci USA, 95, 15264, 10.1073/pnas.95.26.15264

Rivier, 2002, Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists., J Med Chem, 45, 4737, 10.1021/jm0202122

Hoare, 2004, Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists., Biochemistry, 43, 3996, 10.1021/bi036110a

Hauger, 2003, Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation., J Pharmacol Exp Ther, 306, 794, 10.1124/jpet.103.050088

Liaw, 1997, Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach., Mol Endocrinol, 11, 980, 10.1210/mend.11.7.9946

Liaw, 1997, Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors., Mol Endocrinol, 11, 2048, 10.1210/mend.11.13.0034

Perrin, 1998, The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin., Endocrinology, 13, 566, 10.1210/endo.139.2.5757

Sydow, 1999, The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding., Eur J Biochem, 259, 55, 10.1046/j.1432-1327.1999.00007.x

Assil, 2001, Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction., Biochemistry, 40, 1187, 10.1021/bi001758y

Perry, 2005, Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated., J Biol Chem, 280, 11560, 10.1074/jbc.M412914200

Hofmann, 2001, Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1., Protein Sci, 10, 2050, 10.1110/ps.12101

Grigoriadis, 1989, Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation., Endocrinology, 125, 1877, 10.1210/endo-125-4-1877

Assil, 2001, N-Glycosylation of CRF receptor type 1 is important for its ligand-specific interaction., Am J Physiol Endocrinol Metab, 281, E1015, 10.1152/ajpendo.2001.281.5.E1015

Qi, 1997, Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction., Biochemistry, 36, 12442, 10.1021/bi970997r

Xiong, 1995, Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor., Endocrinology, 136, 1828, 10.1210/endo.136.5.7720627

Bohm, 1997, Structural aspects of heterotrimeric G-protein signaling., Curr Opin Biotechnol, 8, 480, 10.1016/S0958-1669(97)80072-9

Hamm, 1996, Heterotrimeric G proteins., Curr Opin Cell Biol, 8, 189, 10.1016/S0955-0674(96)80065-2

Simon, 1991, Diversity of G proteins in signal transduction., Science, 252, 802, 10.1126/science.1902986

Millan, 1987, Receptors and actions of corticotropin-releasing hormone in the primate pituitary gland., J Clin Endocrinol Metab, 64, 1036, 10.1210/jcem-64-5-1036

Weinstein, 2001, Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting., Endocr Rev, 22, 675

Kuryshev, 1995, Corticotropin-releasing hormone stimulation of Ca2+ entry in corticotropes is partially dependent on protein kinase A., Endocrinology, 136, 3925, 10.1210/endo.136.9.7649101

Ulisse, 1990, A novel mechanism of action of corticotropin releasing factor in rat Leydig cells., J Biol Chem, 265, 1964, 10.1016/S0021-9258(19)39926-0

Karteris, 2000, Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit., J Clin Endocrinol Metab, 85, 1989, 10.1210/jcem.85.5.6590

Bastepe, 2002, Receptor-mediated adenylyl cyclase activation through XLα (s), the extra-large variant of the stimulatory G protein α-subunit., Mol Endocrinol, 16, 1912, 10.1210/me.2002-0054

Pasolli, 2000, Characterization of the extra-large G protein α-subunit XLαs I. Tissue distribution and subcellular localization., J Biol Chem, 275, 33622, 10.1074/jbc.M001335200

Wess, 1998, Molecular basis of receptor/G-protein coupling selectivity., Pharmacol Ther, 80, 231, 10.1016/S0163-7258(98)00030-8

Bourne, 1997, How receptors talk to trimeric G proteins., Curr Opin Cell Biol, 9, 134, 10.1016/S0955-0674(97)80054-3

Ladds, 2003, Modified yeast cells to investigate the coupling of G protein-coupled receptors to specific G proteins., Mol Microbiol, 47, 781, 10.1046/j.1365-2958.2003.03336.x

Wietfeld, 2004, Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells., J Biol Chem, 279, 38386, 10.1074/jbc.M405335200

Grammatopoulos, 2001, Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins., J Neurochem, 76, 509, 10.1046/j.1471-4159.2001.00067.x

Aggelidou, 2002, Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells., Proc Natl Acad Sci USA, 99, 3300, 10.1073/pnas.052296399

Blank, 2003, Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning., J Neurosci, 23, 700, 10.1523/JNEUROSCI.23-02-00700.2003

Hillhouse, 2001, Control of intracellular signalling by corticotropin-releasing hormone (CRH) in human myometrium., Front Horm Res, 27, 66, 10.1159/000061042

Grammatopoulos, 2000, Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1α and R2β CRH receptor subtypes and stimulation of Gq-proteins., Mol Endocrinol, 14, 2076

Kenakin, 1995, Agonist-receptor efficacy II: trafficking of receptor signals., Trends Pharmacol Sci, 16, 232, 10.1016/S0165-6147(00)89032-X

Kenakin, 1997, Agonist-specific receptor conformations., Trends Pharmacol Sci, 18, 416, 10.1016/S0165-6147(97)01127-9

Karnik, 2003, Activation of G-protein-coupled receptors: a common molecular mechanism., Trends Endocrinol Metab, 14, 431, 10.1016/j.tem.2003.09.007

Mavros, 2004, CRH-R1α structural domains critical for Gs-protein activation: evidence for distinct receptor active conformations associated with CRH and urocortin binding., Rev Clin Pharmacol Pharmacokinet, 18, 142

Papadopoulou, 2004, Protein kinase A-induced negative regulation of the corticotropin-releasing hormone (CRH) R1a receptor-ERK signal transduction pathway: the critical role of Ser301 for signalling switch and selectivity., Mol Endocrinol, 18, 624, 10.1210/me.2003-0365

Daaka, 1997, Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A., Nature, 390, 88, 10.1038/36362

Tasken, 2004, Localized effects of cAMP mediated by distinct routes of protein kinase A., Physiol Rev, 84, 137, 10.1152/physrev.00021.2003

Shaywitz, 1999, CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals., Annu Rev Biochem, 68, 821, 10.1146/annurev.biochem.68.1.821

Rasmussen, 2004, Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of beta-arrestin 1 recruitment., Eur J Biochem, 271, 4366, 10.1111/j.1432-1033.2004.04371.x

Bayatti, 2005, Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system., Endocrinology, 146, 1205, 10.1210/en.2004-1154

Bayatti, 2003, Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons., Endocrinology, 144, 4051, 10.1210/en.2003-0168

Elliott-Hunt, 2002, Potential signalling pathways underlying corticotropin-releasing hormone’s mediated neuroprotection from excitotoxicity in rat hippocampus., J Neurochem, 80, 416, 10.1046/j.0022-3042.2001.00712.x

McEvoy, 2002, Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway., Ann NY Acad Sci, 966, 119, 10.1111/j.1749-6632.2002.tb04209.x

Graziani, 2002, CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway., Endocrinology, 143, 807, 10.1210/endo.143.3.8694

Huang, 1997, Corticotropin-releasing hormone stimulates the expression of the steroidogenic acute regulatory protein in MA-10 mouse cells., Biol Reprod, 57, 547, 10.1095/biolreprod57.3.547

Miki, 2004, Role of corticotropin-releasing factor receptor type 2 β in urocortin-induced vasodilation of rat aortas., J Pharmacol Sci, 96, 170, 10.1254/jphs.FP0040364

Sanz, 2003, Mechanisms of relaxation by urocortin in renal arteries from male and female rats., Br J Pharmacol, 140, 1003, 10.1038/sj.bjp.0705516

Tojo, 1996, Stimulation by corticotropin-releasing factor of atrial natriuretic peptide and brain natriuretic peptide secretions from cultured neonatal rat cardiomyocytes., Biochem Biophys Res Commun, 225, 340, 10.1006/bbrc.1996.1177

Ikeda, 1998, Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes., Biochem Biophys Res Commun, 250, 298, 10.1006/bbrc.1998.9297

Lefkowitz, 1998, G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization., J Biol Chem, 273, 18677, 10.1074/jbc.273.30.18677

Zhao, 2002, Regulation of nuclear factor-κB by corticotropin-releasing hormone in mouse thymocytes., Mol Endocrinol, 16, 2561, 10.1210/me.2001-0334

Facci, 2003, Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors., Neuropharmacology, 45, 623, 10.1016/S0028-3908(03)00211-9

Haug, 2000, Protein kinase A mediates the modulation of the slow Ca(2+)-dependent K(+) current, I(sAHP), by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons., J Neurophysiol, 83, 2071, 10.1152/jn.2000.83.4.2071

Nemoto, 2005, Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cells., Biochem Biophys Res Commun, 330, 821, 10.1016/j.bbrc.2005.03.031

Rossant, 1999, Corticotropin-releasing factor type 1 and type 2α receptors regulate phosphorylation of calcium/cyclic adenosine 3′,5′-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase., Endocrinology, 140, 1525, 10.1210/endo.140.4.6656

Boutillier, 1991, The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells., Mol Endocrinol, 5, 1301, 10.1210/mend-5-9-1301

Waeber, 1998, Transcriptional activation of the macrophage migration-inhibitory factor gene by the corticotropin-releasing factor is mediated by the cyclic adenosine 3′,5′-monophosphate responsive element-binding protein CREB in pituitary cells., Mol Endocrinol, 12, 698

Murphy, 1997, Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors., Mol Endocrinol, 11, 39, 10.1210/mend.11.1.9874

Kovalovsky, 2002, Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways., Mol Endocrinol, 16, 1638, 10.1210/mend.16.7.0863

Peeters, 2004, Transcriptional response to corticotropin-releasing factor in AtT-20 cells., Mol Pharmacol, 66, 1083, 10.1124/mol.104.000950

Sirianni, 2005, Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells., J Clin Endocrinol Metab, 90, 5393, 10.1210/jc.2005-0680

Sirianni, 2005, Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells., J Clin Endocrinol Metab, 90, 279, 10.1210/jc.2004-0865

Zbytek, 2004, Corticotropin-releasing hormone stimulates NF-κB in human epidermal keratinocytes, J Endocrinol, 181, R1, 10.1677/joe.0.181r001

Karalis, 2004, NF-κB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene., J Biol Chem, 279, 10837, 10.1074/jbc.M313063200

Dermitzaki, 2002, Corticotropin-releasing hormone (CRH) induces Fas ligand production and apoptosis in PC12 cells via activation of p38 MAPK., J Biol Chem, 277, 12280, 10.1074/jbc.M111236200

Kiang, 1997, Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells., Eur J Pharmacol, 329, 237, 10.1016/S0014-2999(97)00165-9

Cantarella, 2001, Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors., Br J Pharmacol, 134, 837, 10.1038/sj.bjp.0704322

Makrigiannakis, 2001, Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance., Nat Immunol, 2, 1018, 10.1038/ni719

Grammatopoulos, 1999, Basal and interleukin-1β-stimulated prostaglandin production from cultured human myometrial cells: differential regulation by corticotropin-releasing hormone., J Clin Endocrinol Metab, 84, 2204

Kostic, 2001, Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells., Mol Endocrinol, 15, 1010, 10.1210/mend.15.6.0648

Malagoli, 2000, Synergistic role of cAMP and IP(3) in corticotropin-releasing hormone-induced cell shape changes in invertebrate immunocytes., Peptides, 21, 175, 10.1016/S0196-9781(99)00203-X

Karteris, 2004, Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility., Endocrinology, 145, 890, 10.1210/en.2003-1210

Brar, 2004, Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides., Endocrinology, 145, 1718, 10.1210/en.2003-1023

Refojo, 2005, Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas., Proc Natl Acad Sci USA, 102, 6183, 10.1073/pnas.0502070102

Sananbenesi, 2003, Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory., J Neurosci, 23, 11436, 10.1523/JNEUROSCI.23-36-11436.2003

Pedersen, 2002, Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I., J Neurosci, 22, 404, 10.1523/JNEUROSCI.22-02-00404.2002

Kageyama, 2003, Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta., J Cardiovasc Pharmacol, 42, 561, 10.1097/00005344-200310000-00015

Radulovic, 2003, Corticotropin-releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases., J Neurochem, 84, 1074, 10.1046/j.1471-4159.2003.01594.x

Park, 2005, Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway., J Invest Dermatol, 124, 751, 10.1111/j.0022-202X.2005.23656.x

Stork, 2002, Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation., Trends Cell Biol, 12, 258, 10.1016/S0962-8924(02)02294-8

Yue, 1998, Phosphorylation of serine 1105 by protein kinase A inhibits phospholipase Cβ3 stimulation by Gαq., J Biol Chem, 273, 18023, 10.1074/jbc.273.29.18023

Petraglia, 1999, Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro., J Clin Endocrinol Metab, 84, 1420, 10.1210/jcem.84.4.5585

Ohmichi, 1997, Role of mitogen-activated protein kinase pathway in prostaglandin F2α-induced rat puerperal uterine contraction., Endocrinology, 138, 3103, 10.1210/endo.138.8.5305

Bian, 2003, Nitric oxide (NO)-biogeneration, regulation, and relevance to human diseases., Front Biosci, 8, 264, 10.2741/997

Clifton, 1995, Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway., J Clin Endocrinol Metab, 80, 2888

Maudsley, 2005, The origins of diversity and specificity in G protein-coupled receptor signaling., J Pharmacol Exp Ther, 314, 485, 10.1124/jpet.105.083121

Chen, 2005, Urocortin-induced relaxation in the human internal mammary artery., Cardiovasc Res, 65, 913, 10.1016/j.cardiores.2004.11.018

Dautzenberg, 2002, GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization., Biochem Biophys Res Commun, 298, 303, 10.1016/S0006-291X(02)02463-4

Kostic, 2004, Receptor-controlled phosphorylation of α 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5′-monophosphate production in pituitary cells., Mol Endocrinol, 18, 458, 10.1210/me.2003-0015

Freedman, 1996, Desensitization of G protein-coupled receptors., Recent Prog Horm Res, 51, 319

Claing, 2002, Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins., Prog Neurobiol, 66, 61, 10.1016/S0301-0082(01)00023-5

Nikodemova, 2002, Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary., Arch Physiol Biochem, 110, 123, 10.1076/apab.110.1.123.901

Teli, 2005, Regulation of corticotropin-releasing hormone receptor type 1α signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization., Mol Endocrinol, 19, 474, 10.1210/me.2004-0275

Dieterich, 1996, Homologous desensitization of human corticotropin-releasing factor 1 receptor in stable transfected mouse fibroblast cells., Brain Res, 710, 287, 10.1016/0006-8993(95)01480-2

Roseboom, 2001, Persistent corticotropin-releasing factor (1) receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32., Brain Res Mol Brain Res, 92, 115, 10.1016/S0169-328X(01)00162-0

Hauger, 1997, Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery., J Neurochem, 68, 2308, 10.1046/j.1471-4159.1997.68062308.x

Hauger, 2000, Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization., Biochem Biophys Res Commun, 268, 572, 10.1006/bbrc.2000.2183

Pitcher, 1998, G-protein receptor kinases., Ann Rev Biochem, 67, 653, 10.1146/annurev.biochem.67.1.653

Kageyama, 2006, G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs., Endocrinology, 147, 441, 10.1210/en.2005-0376